<DOC>
	<DOCNO>NCT01431755</DOCNO>
	<brief_summary>The objective study evaluate pain-relieving effect safety add lidocaine hydrochloride Restylane SubQ evaluate esthetic improvement obtain . The study product administer cheek .</brief_summary>
	<brief_title>A Study Treatment Preference During Cheek Contouring Comparing RestylaneÂ® SubQ With Without Addition Lidocaine Hydrochloride</brief_title>
	<detailed_description>The Restylane SubQ gel intend use facial tissue augmentation . The lidocaine content design reduce subject 's pain treatment . The objective split-face design study evaluate pain-relieving effect safety add lidocaine hydrochloride Restylane SubQ evaluate esthetic improvement obtain dermal filler use global esthetic improvement scale ( GEIS ) .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>18 year age old . Intent undergo contour cheek 1.5 2 ml Restylane SubQ per cheek . Sufficient symmetry face order ensure similar volume inject , similar injection technique time injection . Signed informed consent . Surgery midface include aesthetic facial surgical therapy , sinus surgery dental root surgery within past 12 month . Chronic infection head neck region . Ongoing infection mouth . Tendency edema , puffiness swell zygomatic prominence . Active skin disease , inflammation related condition , infection , psoriasis herpes zoster near area treat . Previous hypersensitivity hyaluronic acid local anesthetic . Concomitant anticoagulant therapy therapy inhibitor platelet aggregation within 10 day prior treatment , history bleeding disorder . Cancerous precancerous lesion area treat . Previous tissue augment therapy area treat nonpermanent filler , laser treatment , chemical peeling last 6 month . Permanent implant place area treat . Reduced sensibility facial region e.g . due trauma , facial pareses , previous tissue augment therapy , aesthetic facial surgical therapy , laser treatment , peel . Pregnancy breast feed . Participation clinical study within 30 day prior inclusion . Other condition prevent subject enter study Investigator 's opinion e.g . subject likely avoid facial cosmetic treatment level upper orbital rim , subject anticipate unreliable incapable understand VAS assessment , insufficient tissue support cover treatment area .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>